EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Clinical Outcomes Post‐Transcatheter Aortic Valve Replacement in Patients With Hypertrophic Obstructive Cardiomyopathy

Muhammad Usman Almani iD, Vibhor Ahluwalia, Muhammad Yousuf, Jafar Alzubi, Mohammad Hamza iD, Raphael Bonita, Christian Witzke

Catheterization and Cardiovascular Interventions · 2025

DOI: 10.1002/ccd.70201 ↗

At a glance

Journal article in Catheterization and Cardiovascular Interventions, 2025. Written by Muhammad Usman Almani and 6 co-authors. Institution: Division of Cardiology, Jefferson Einstein Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA. Major MEDLINE topics: Cardiomyopathy, Hypertrophic, Transcatheter Aortic Valve Replacement, Aortic Valve Stenosis, Aortic Valve. Cited 2 times so far (Crossref); 19 references. The full text is freely available (open access, CC BY 4.0). Funded by: The authors received no specific funding for this work..

AbstractSubjectsDati bibliograficiCiteRelated studies

Abstract (original language)

Background

Patients with hypertrophic obstructive cardiomyopathy (HOCM) were excluded from all major trials for transcatheter aortic valve replacement (TAVR). “Suicide left ventricle” occurring after TAVR is postulated to occur as a result of chronic pressure overload from fixed obstruction that is acutely relieved after the valve deployment resulting in worsening left ventricular outflow tract obstruction.

Aims

The aim of this study was to determine the clinical and readmission outcomes in HOCM patients undergoing TAVR.

Methods

Data was extracted from the National Inpatient and National Readmission 2016−2020 Databases. We performed multivariable Logistic regression analysis to determine the odds of in‐hospital mortality and other relevant clinical outcomes in patients undergoing TAVR with and without comorbid HOCM. Multivariable Cox regression analysis was used to assess 30‐day hospital readmission in HOCM patients undergoing TAVR.

Results

We identified 296,670 patients who underwent TAVR, of whom 534 (0.2%) had comorbid HOCM. The patients undergoing TAVR with comorbid HOCM had more than threefold higher risk of in‐hospital mortality (adjusted odds ratio: 3.47, 95% CI 1.37–8.81, p = 0.009) when compared to patients without HOCM. Additionally, patients undergoing TAVR with comorbid HOCM had a higher risk of atrioventricular blocks, cardiogenic shock, acute kidney injury, and the need for intubation. There was no difference in readmission outcomes post‐TAVR among patients with and without HOCM.

Conclusion

Our analysis of a large, real‐world cohort of patients undergoing TAVR showed that patients with HOCM have a significantly higher risk of in‐hospital mortality and procedural complications when compared to patients without HOCM.

Subjects

MeSH terms (MEDLINE)

Cardiomyopathy, HypertrophicTranscatheter Aortic Valve ReplacementAortic Valve StenosisAortic ValveHumansMaleHospital MortalityFemaleTreatment OutcomeAgedRisk FactorsUnited StatesRisk AssessmentTime FactorsDatabases, FactualPatient ReadmissionAged, 80 and overRetrospective StudiesComorbidityPostoperative Complications

Author keywords

hypertrophic obstructive cardiomyopathysuicide left ventricletranscatheter aortic valve replacement

Authors and institutions

  • Division of Cardiology, Jefferson Einstein Hospital, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
  • Department of Internal Medicine, Nazareth Hospital, Philadelphia, Pennsylvania, USA.
  • Division of Medicine, Mayo Clinic, Rochester, Minnesota, USA.
  • Division of Cardiology, Yale University Hospital, New Haven, Connecticut, USA.
  • Division of Medicine, Guthrie Medical Group, Cortland, New York, USA.

ORCID profiles: Muhammad Usman Almani, Mohammad Hamza

Funding

  • The authors received no specific funding for this work.

Cite

APA

Almani, M. U., Ahluwalia, V., Yousuf, M., Alzubi, J., Hamza, M., Bonita, R., & Witzke, C. (2025). Clinical Outcomes Post‐Transcatheter Aortic Valve Replacement in Patients With Hypertrophic Obstructive Cardiomyopathy. Catheterization and Cardiovascular Interventions. https://doi.org/10.1002/ccd.70201

Vancouver

Almani MU, Ahluwalia V, Yousuf M, Alzubi J, Hamza M, Bonita R, et al. Clinical Outcomes Post‐Transcatheter Aortic Valve Replacement in Patients With Hypertrophic Obstructive Cardiomyopathy. Catheterization and Cardiovascular Interventions. 2025. doi:10.1002/ccd.70201

BibTeX
@article{Almani2025,
  author = {Almani, Muhammad Usman and Ahluwalia, Vibhor and Yousuf, Muhammad and Alzubi, Jafar and Hamza, Mohammad and Bonita, Raphael and Witzke, Christian},
  title = {Clinical Outcomes Post‐Transcatheter Aortic Valve Replacement in Patients With Hypertrophic Obstructive Cardiomyopathy},
  journal = {Catheterization and Cardiovascular Interventions},
  year = {2025},
  doi = {10.1002/ccd.70201}
}
Start for free →